Purpose of this Study
We are doing this study to learn more about the performance and safety of the Medtronic Hugo RAS (Robot Assisted Surgery) system when it is used to assist with urologic surgical procedures.
Who Can Participate?
Eligibility
Adults ages 22+ who:
- Plan to have a radical prostatectomy, radical cystectomy, or nephrectomy (partial or radical) surgical procedure
-Do not have any medical conditions that make surgery risky (e.g., an active infection)
-Are not pregnant
For more information about who can join this study, please contact the study team at urologyresearch@duke.edu.
- Plan to have a radical prostatectomy, radical cystectomy, or nephrectomy (partial or radical) surgical procedure
-Do not have any medical conditions that make surgery risky (e.g., an active infection)
-Are not pregnant
For more information about who can join this study, please contact the study team at urologyresearch@duke.edu.
Age Range
18-110
Sex/Genders
Male (cisgender)
Female (cisgender)
Non-binary or gender fluid
Transgender male
Transgender female
Looking for Healthy Participants
No
What is Involved?
If you choose to join this study, the Medtronic Hugo RAS System will be used to assist with your surgical procedure.
You will visit our clinic one time, 30 days after your operation, if your surgery is not related to cancer. If your surgery is related to cancer, you will have follow-up visits to our clinic once every year for 5 years.
You will visit our clinic one time, 30 days after your operation, if your surgery is not related to cancer. If your surgery is related to cancer, you will have follow-up visits to our clinic once every year for 5 years.
Locations
Duke University Hospital
Visit Timing
Weekdays
Compensation
No
Spanish Materials Available
Yes
Study Details
Full Title
A prospective, multi-center, single-arm study of the Medtronic Hugo? Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO)
Principal Investigator
Michael
Abern
Protocol Number
PRO00108661
Phase
N/A
Enrollment Status
OPEN TO ACCRUAL